Holen Sie sich die Stockscreener-App
0.6073
3.73%
-0.0235
Handel nachbörslich:
.61
0.0027
+0.44%
Finanzdaten der Vistagen Therapeutics Inc-Aktie (VTGN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
17.44%
0.303
|
0.258 | 0.244 | -0.015 | 0.234 |
Operating Expenses
|
2.27%
19.85
|
20.31 | 16.05 | 14.48 | 15.35 |
| Benefits Costs and Expenses |
2.40%
19.20
|
19.68 | 15.34 | 13.62 | 14.32 |
| Costs And Expenses |
2.40%
19.20
|
19.68 | 15.34 | 13.62 | 14.32 |
| Operating Income/Loss |
2.53%
-19.55
|
-20.05 | -15.80 | -14.49 | -15.12 |
| Income/Loss From Continuing Operations Before Tax |
2.67%
-18.90
|
-19.42 | -15.10 | -13.63 | -14.09 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
2.67%
-18.90
|
-19.42 | -15.10 | -13.63 | -14.09 |
|
Net Income/Loss
|
2.67%
-18.90
|
-19.42 | -15.10 | -13.63 | -14.09 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
18.14%
42.23
|
35.75 | 31.93 | 0.2276 | 30.71 |
| Diluted Average Shares |
18.14%
42.23
|
35.75 | 31.93 | 0.2276 | 30.71 |
| Basic Earnings Per Share |
16.67%
-0.45
|
-0.54 | -0.47 | -0.44 | -0.46 |
| Diluted Earnings Per Share |
16.67%
-0.45
|
-0.54 | -0.47 | -0.44 | -0.46 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):